Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2420336
Max Phase: Preclinical
Molecular Formula: C27H25N3O3
Molecular Weight: 439.52
Molecule Type: Small molecule
Associated Items:
ID: ALA2420336
Max Phase: Preclinical
Molecular Formula: C27H25N3O3
Molecular Weight: 439.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(NCCCn1ccc(=O)[nH]c1=O)C(c1ccccc1)(c1ccccc1)c1ccccc1
Standard InChI: InChI=1S/C27H25N3O3/c31-24-17-20-30(26(33)29-24)19-10-18-28-25(32)27(21-11-4-1-5-12-21,22-13-6-2-7-14-22)23-15-8-3-9-16-23/h1-9,11-17,20H,10,18-19H2,(H,28,32)(H,29,31,33)
Standard InChI Key: ACHGSTRZZKBPEE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 439.52 | Molecular Weight (Monoisotopic): 439.1896 | AlogP: 3.08 | #Rotatable Bonds: 8 |
Polar Surface Area: 83.96 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.06 | CX Basic pKa: | CX LogP: 3.65 | CX LogD: 3.65 |
Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.33 | Np Likeness Score: -0.67 |
1. Hampton SE, Schipani A, Bosch-Navarrete C, Recio E, Kaiser M, Kahnberg P, González-Pacanowska D, Johansson NG, Gilbert IH.. (2013) Investigation of acyclic uridine amide and 5'-amido nucleoside analogues as potential inhibitors of the Plasmodium falciparum dUTPase., 21 (18): [PMID:23916149] [10.1016/j.bmc.2013.07.004] |
Source(1):